[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO1994000433A1 - Process for making phenylthiomethylpyridinylalkenoates - Google Patents

Process for making phenylthiomethylpyridinylalkenoates Download PDF

Info

Publication number
WO1994000433A1
WO1994000433A1 PCT/US1993/006177 US9306177W WO9400433A1 WO 1994000433 A1 WO1994000433 A1 WO 1994000433A1 US 9306177 W US9306177 W US 9306177W WO 9400433 A1 WO9400433 A1 WO 9400433A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
phenyl
halo
lower alkoxy
group
Prior art date
Application number
PCT/US1993/006177
Other languages
French (fr)
Inventor
Robert A. Daines
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Priority to CA002138955A priority Critical patent/CA2138955A1/en
Priority to AU46557/93A priority patent/AU678979B2/en
Priority to EP93916841A priority patent/EP0649408A4/en
Priority to US08/356,353 priority patent/US5700943A/en
Priority to JP50263894A priority patent/JP3181917B2/en
Publication of WO1994000433A1 publication Critical patent/WO1994000433A1/en
Priority to KR1019940704738A priority patent/KR950702184A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Definitions

  • the field of this invention is that of a process for making certain thioethers by coupling a chloromethyl pyridyl compound with thiophenols and related mercaptans.
  • the products of this coupling, the thioethers and their related sulfoxides and sulfones are useful for treating diseases arising from or related to leukotrienes, particularly leukotriene B4. As such there utility lies in antagonizing the affects of leukotrienes.
  • This invention relates to a process for making these compounds and other compounds of a similar nature where a chloromethylpridine is coupled with a thiophenol or benzylic mercaptan.
  • This invention covers a method for making a compound of formula I
  • R j contains an ⁇ , ⁇ -unsaturated carbonyl group and the designation (R) n indicates hydrogen or one or more non-hydrogen radicals capable of being covalently bonded on the pyridyl and phenyl rings and m is 0 -5; which method comprises coupling a chloromethylpyridine of formula II with a thiol of formula HI in the presence of l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) under an inert gas at a temperature between about ambient and 100° C for a period sufficient to effect the coupling.
  • DBU l,8-diazabicyclo[5.4.0]undec-7-ene
  • Formula II Formula II Formula HI where Ri is defined above and (R) n is hydrogen or one or more radicals which can be substituted on either the pyridyl or phenyl ring and m is 0 - 5.
  • the imdefined carbonyl function valence can be a carbon- carbon bond, a carbon-heteroatom bond wherein the heteroatom is oxygen, nitrogen, sulfur or the like, including phosphorus.
  • This invention is intended to cover all the enventualities where a thiol of the type illustrated is reacted with a pyridyl derivative which has an ⁇ , ⁇ -unsaturated carbonyl system at the 2-position which can undergo a Michael addition reaction with the thiol.
  • the (R) n designation is used here to indicate that one or more groups may be present on either the pyridyl ring or the phenyl ring. This invention also includes the case where each of these R groups is hydrogen. It is expected that any number and combination of substituents may be present on either ring. The only limitation envisioned is that the one of these groups must not interfere with the coupling reaction to a degree as to render the reaction impractical, ie, it does not occur at all, the yield is vanishing small, the wrong product is obtained in an undesirable amount.
  • a given group may be in protected form, for example a carboxylate function may be present in the form of an ester, the acid being regenerated by hydrolytic, catalytic or enzymatic means once the coupling reaction is completed.
  • the invention is that of the use of DBU to affect the coupling of the chloro and the thiol to achieve the thioether and is to be viewed as only so limited.
  • aliphatic is intended to include saturated and unsaturated radicals. This includes normal and branched chains, saturated or mono or poly unsaturated chains where both double and triple bonds may be present in any combination.
  • lower alkyl means an alkyl group of 1 to 6 carbon atoms in any isomeric form, but particularly the normal or linear form.
  • Lower alkoxy means the group lower alkyl-O-.
  • Acyl-lower alkyl refers to the group (O)C-lower alkyl where the carbonyl carbon is counted as one of the carbons of the 1 to 6 carbons noted under the definition of lower alkyl.
  • Halo refers to and means fluoro, chloro, bromo or iodo. The phenyl ring may be substituted with one or more of these radicals.
  • substituents may be the same or different, such as where there are three chloro groups, or a combination of chloro and alkyl groups and further where this latter combination may have different alkyl radicals in the chloro/alkyl pattern.
  • Oxides of the pyridyl ring nitrogen may be prepared by means known in the art and as illustrated herein. These are to be considered part of the invention.
  • Compounds with a -chiral center may be administered as a racemic mixture or the racemates may be separated and the individual enantiomer used alone.
  • the compound l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) is available from Aldrich.
  • DBU diazabicyclo[5.4.0]undec-7-ene
  • the thiol or mercaptan is dissolved in a dry polar solvent like acetonitrile to which is added about an equivalent of the chloromethylpyridine adduct to be coupled.
  • a dry polar solvent like acetonitrile
  • 2 to 5 equivalents of DBU as measured against the thiol or mercaptan are added.
  • About 3 equivalents of DBU are preferred. Dry conditions are maintained throughout the course of setting up and running the reaction.
  • An inert atmosphere is used, preferably argon. The reaction is stirred at between about ambient temperature and 100° C for several hours.
  • the reaction can be made to go in a useful manner by heating the stirred reactants for 2 to 4 hours under an argon gas at a temperature of about 50° C. Thereafter the reaction is cooled and the product, the thioether, is recovered and purified by conventional means.
  • Preferred products of this reaction are those compounds of formula
  • Cio-alip atic where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo, or R is Cj to C20-aliphatic-O-, or R is unsubstituted or substituted phenyl-Ci to CiQ-al ⁇ hatic-O- where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo;
  • R2 is H, lower alkoxy, halo, -CN, -(CH2) n R4 where n is 0 - 5, lower alkyl, or CF3;
  • R3 is H, lower alkoxy, halo, lower alkyl, CF3, -CN, -(CH2) n R4 where n is 0 - 5,
  • R4 is tetrazol-5-yl or COR5; and R5 is lower alkoxy, C ⁇ O- ⁇ 0 or phenyl(CH2) ⁇ -3CO.
  • R2 and R3 are both hydrogen, both halo, both methyl, or both methoxy.
  • Another preferred set of compounds are those where R2 is COR5 and R3 is hydrogen.
  • the 2,6- dichloro is a preferred product.
  • Specific preferred products are: (E)-methyl 3-[3-[4-(4-methoxyphenyl)butyloxy]-6-[(2,6- dichlorophenylthio)methyl]-2-pyridinyl]-2-propenoate,
  • the first step was to make the intermediates needed for forming those R groups where the intermediates were not available commercially.
  • This chemistry is illustrated for the case of the substituted phenyl-Ci to C ⁇ o-aliphatic-0- groups.
  • the same or similar chemistry has been disclosed in published patent applications, for example PCT international application numbers PCT/US91/03772, PCT/US91/03940, and PCT/US91/03399.
  • the chemistries set out in those documents can be used in place of or in conjunction with those given here to prepare the R groups of formula I.
  • the substituted chloromethylpyridine is prepared next, as opposed to the thiol intermediate, but this is not critical to the practice of the invention.
  • Base or acid
  • a free acid can be obtained from the salt by aridifying a solution of the salt.
  • Esters and amides can be prepared using standard reaction conditions and reagents. Tetrazoles are prepared from the corresponding acid halide, e.g., the acid chloride, by literature methods.
  • Trmlring the right hand portion of formula I can be purchased from o commercial sources.
  • a fist is as follows: 2,5-dichlorothiophenol, 2,6-dimethylthiophenol,2-chloro-6-fluorobenzyl mercaptan, and 2,4-difluorobenzyl thiol.
  • Other thiols can be made by published chemistry; that chemistry involves converting a haloalkylphenyl (the bromo form is preferred) compound to the corresponding mercaptan by treating the bromo compound with thiourea followed by base hydrolysis.
  • the thiophenols can be prepared by thermal rearrangement of the corresponding thiocarbamate followed by hydrolysis.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention relates to a process of making a compound of formula (I) where R1 contains an α,β-unsaturated carbonyl group and Rn is hydrogen or nonhydrogen radicals which do not have a functional group which interferes with the coupling reaction, which process comprises coupling a thiolphenol or phenylalkylmercaptan with a chloromethylpyridine in the presence of DBU under an inert atmosphere. These compounds are leukotriene antagonists and as such can be used in treating various diseases associated with leukotrienes.

Description

Process for making phenylthiomethylpyridinyialkenoates.
Scone of the Invention The field of this invention is that of a process for making certain thioethers by coupling a chloromethyl pyridyl compound with thiophenols and related mercaptans. The products of this coupling, the thioethers and their related sulfoxides and sulfones are useful for treating diseases arising from or related to leukotrienes, particularly leukotriene B4. As such there utility lies in antagonizing the affects of leukotrienes.
Background of the Invention A series of thioethers represented by the general formula
Figure imgf000003_0001
have been discovered to be useful in treating diseases involving the leukotriene cascade, particularly those diseases believed to be associated with or caused by the dihydroxyleukotrienes Qeukotriene B4). These thioethers can be found in certain publications, particularly PCT application serial number PCT/US91/03772. A method for preparing those novel therapeutic agents is disclosed therein along with a description of - utility and the background of the family of bioactive lipids known as the leukotrienes.
This invention relates to a process for making these compounds and other compounds of a similar nature where a chloromethylpridine is coupled with a thiophenol or benzylic mercaptan. Summary of the Invention
This invention covers a method for making a compound of formula I
Figure imgf000003_0002
where Rj contains an α,β-unsaturated carbonyl group and the designation (R)n indicates hydrogen or one or more non-hydrogen radicals capable of being covalently bonded on the pyridyl and phenyl rings and m is 0 -5; which method comprises coupling a chloromethylpyridine of formula II with a thiol of formula HI in the presence of l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) under an inert gas at a temperature between about ambient and 100° C for a period sufficient to effect the coupling.
Figure imgf000004_0001
Formula II Formula HI where Ri is defined above and (R)n is hydrogen or one or more radicals which can be substituted on either the pyridyl or phenyl ring and m is 0 - 5.
General Embodiments
The following definitions are used in describing this invention.
An α,β-unsaturated carbonyl group is illustrated by -CH=CH-C(=0)- or -CsC-C(=0)-. The imdefined carbonyl function valence can be a carbon- carbon bond, a carbon-heteroatom bond wherein the heteroatom is oxygen, nitrogen, sulfur or the like, including phosphorus. This invention is intended to cover all the enventualities where a thiol of the type illustrated is reacted with a pyridyl derivative which has an α,β-unsaturated carbonyl system at the 2-position which can undergo a Michael addition reaction with the thiol.
The (R)n designation is used here to indicate that one or more groups may be present on either the pyridyl ring or the phenyl ring. This invention also includes the case where each of these R groups is hydrogen. It is expected that any number and combination of substituents may be present on either ring. The only limitation envisioned is that the one of these groups must not interfere with the coupling reaction to a degree as to render the reaction impractical, ie, it does not occur at all, the yield is vanishing small, the wrong product is obtained in an undesirable amount. It should be understood that a given group may be in protected form, for example a carboxylate function may be present in the form of an ester, the acid being regenerated by hydrolytic, catalytic or enzymatic means once the coupling reaction is completed. The invention is that of the use of DBU to affect the coupling of the chloro and the thiol to achieve the thioether and is to be viewed as only so limited. As for other terms, "aliphatic" is intended to include saturated and unsaturated radicals. This includes normal and branched chains, saturated or mono or poly unsaturated chains where both double and triple bonds may be present in any combination. The phrase "lower alkyl" means an alkyl group of 1 to 6 carbon atoms in any isomeric form, but particularly the normal or linear form. "Lower alkoxy" means the group lower alkyl-O-. "Acyl-lower alkyl" refers to the group (O)C-lower alkyl where the carbonyl carbon is counted as one of the carbons of the 1 to 6 carbons noted under the definition of lower alkyl. "Halo" refers to and means fluoro, chloro, bromo or iodo. The phenyl ring may be substituted with one or more of these radicals. Multiple substituents may be the same or different, such as where there are three chloro groups, or a combination of chloro and alkyl groups and further where this latter combination may have different alkyl radicals in the chloro/alkyl pattern. Oxides of the pyridyl ring nitrogen may be prepared by means known in the art and as illustrated herein. These are to be considered part of the invention.
If by some combination of substituents, a chiral center is created or another form of an isomeric center is created in a compound of this invention, all forms of such isomer(s) are intended to be covered herein.
Compounds with a -chiral center may be administered as a racemic mixture or the racemates may be separated and the individual enantiomer used alone.
The compound l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) is available from Aldrich. To effect the coupling, the thiol or mercaptan is dissolved in a dry polar solvent like acetonitrile to which is added about an equivalent of the chloromethylpyridine adduct to be coupled. Then between 2 to 5 equivalents of DBU as measured against the thiol or mercaptan are added. About 3 equivalents of DBU are preferred. Dry conditions are maintained throughout the course of setting up and running the reaction. An inert atmosphere is used, preferably argon. The reaction is stirred at between about ambient temperature and 100° C for several hours. The reaction can be made to go in a useful manner by heating the stirred reactants for 2 to 4 hours under an argon gas at a temperature of about 50° C. Thereafter the reaction is cooled and the product, the thioether, is recovered and purified by conventional means.
Preferred products of this reaction are those compounds of formula
Figure imgf000006_0001
Formula IA or an N-oxide, or a pharmaceutically acceptable salt, where m is 0 - 5; R is Ci to C20-aliphatic, unsubstituted or substituted phenyl-Cj to
Cio-alip atic where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo, or R is Cj to C20-aliphatic-O-, or R is unsubstituted or substituted phenyl-Ci to CiQ-alφhatic-O- where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo;
Rl is -(CH2)xCH=CHCORy, or -(CH2)xCH=CHCHO, where x is 0 - 2 and Ry is -OH or an ester thereof or NH2 or a substituted amide derivative thereof; R2 is H, lower alkoxy, halo, -CN, -(CH2)nR4 where n is 0 - 5, lower alkyl, or CF3;
R3 is H, lower alkoxy, halo, lower alkyl, CF3, -CN, -(CH2)nR4 where n is 0 - 5,
R4 is tetrazol-5-yl or COR5; and R5 is lower alkoxy, CΑ^^O-β^0 or phenyl(CH2)θ-3CO.
The more preferred products are those where R is substituted phenyl-C2 to Cg alkoxy, particularly the unsubstituted-phenyl(CH2)2-8"0* group, or the -fluoro- or -methoxyphenyl(CH2)2-8"0- group, or CH3(CH2)7-9-0-; m is 0 - 5, most preferably 0, 1, or 2; Ri is HO2C- CH=CH-, or HO2C-CH2CH2- or a salt, ester or amide derivative thereof. Another sub-group of preferred products are those where R2 and R3 are both hydrogen, both halo, both methyl, or both methoxy. Another preferred set of compounds are those where R2 is COR5 and R3 is hydrogen. The 2,6- dichloro is a preferred product. Specific preferred products are: (E)-methyl 3-[3-[4-(4-methoxyphenyl)butyloxy]-6-[(2,6- dichlorophenylthio)methyl]-2-pyridinyl]-2-propenoate,
(E)-methyl 3-[3-[4-(4-methoxyphenyl)butyloxy]-6-[phenylthiomethyl]- 2-pyridinyl]-2-propenoate. (E)-methyl 3-[3-[2-(4-methoxyphenyl)ethyloxy]-6-[(2,6- dichlorophenylthio)-methyl]-2-pyridinyl]-2-propenoate,
(E)-methyl 3-[3-[2-(4-fluorophenyl)ethyloxy]-6-[(2,6- dicMorophenylthio)methyl]-2-pyridinyl]-2-propenoate, or (E)-methyl 3-[3-[8-(4-methoxyphenyl)octyloxy]-6-[(3-carbomethoxy- benzylthio)methyl]-2-pyridinyl]-2-propenoate.
Synthesis Several methods, variations on the same process, have been used for preparing these compounds. In general, the approach taken was to first make the intermediates needed to make the R group, then to prepare the phenyl intermediate needed for forming the core structure of formula I; the pyridyl intermediate was then prepared and reacted with the phenyl intermediate to form the core structure. Salts, free acids, amides, alternative esters and the like were then prepared.
As noted, the first step was to make the intermediates needed for forming those R groups where the intermediates were not available commercially. This chemistry is illustrated for the case of the substituted phenyl-Ci to Cιo-aliphatic-0- groups. The same or similar chemistry has been disclosed in published patent applications, for example PCT international application numbers PCT/US91/03772, PCT/US91/03940, and PCT/US91/03399. The chemistries set out in those documents can be used in place of or in conjunction with those given here to prepare the R groups of formula I. Usually the substituted chloromethylpyridine is prepared next, as opposed to the thiol intermediate, but this is not critical to the practice of the invention. Making the substituted 6-chloromethylpyridyl intermediate can begin with the starting compound and the chemistry disclosed in the PCT application PCT/US91/03772 and the other PCT cases cited above. The chemistry set out in the '03772 case can be used to convert the starting material, 2,6-lutidine-<χ2,3-diol, to, for example, the 2-(E-2- carboxymethylethenyl)-3-[4-(4-methoxyphenyl)butyloxy]-6- chloromethylpyridine. This is illustrated in Scheme I given below. Novel chemistry, both conditions and the reagent DBU, are then used to couple the thiophenol with the chloromethyl substituted pyridine in order to make the basic structure of formula I. Base, or acid, can then be used to hydrolyze any ester group, if so desired. A free acid can be obtained from the salt by aridifying a solution of the salt. Esters and amides can be prepared using standard reaction conditions and reagents. Tetrazoles are prepared from the corresponding acid halide, e.g., the acid chloride, by literature methods.
Using the precursors prepared as per the noted PCT applications or which have been purchased from a commercial source, and the steps outlined in Scheme I, can be used to prepare compounds of formula I.
Scheme I
Figure imgf000008_0001
A general description of the conditions and reagents which can be used for converting the diol to the 6-(chloromethyl)pyridine compound can be found in PCT application number PCT US91/03772. That description of the generahzed case for each step is incorporated herein by reference along with the specific chemistry set out in the Examples of that apphcation. A number of thiophenols and thioalkylphenyl compounds useful for
Trmlring the right hand portion of formula I can be purchased from o commercial sources. A fist, not intended to be exhaustive, is as follows: 2,5-dichlorothiophenol, 2,6-dimethylthiophenol,2-chloro-6-fluorobenzyl mercaptan, and 2,4-difluorobenzyl thiol. Other thiols can be made by published chemistry; that chemistry involves converting a haloalkylphenyl (the bromo form is preferred) compound to the corresponding mercaptan by treating the bromo compound with thiourea followed by base hydrolysis. Alternatively the thiophenols can be prepared by thermal rearrangement of the corresponding thiocarbamate followed by hydrolysis.
Coupling the thiol with the chloromethylpyridyl compoimd using a novel method which employs l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and an appropriate solvent, for example CH3CN. Moisture is excluded from the system and an inert gas is used, for example argon. A slightly elevated temperature is preferred, one that is about 50° C or so; the coupling reaction is complete in about 3 hours. Once the core structure is prepared any ester can be hydrolyzed with acid or base, base is preferred, or that acid can be converted to another ester, an amide or another salt.
Specific Embodiments
The following examples are given to illustrate how to make and use the compounds of this invention. These Examples are just that, examples, and are not intended to circumscribe or otherwise limit the scope of this invention. Reference is made to the claims for defining what is reserved to the inventors.
Ex mpl 1
(EVLithium 3-r3-r4-(4-methoxyphenvDbutyloxy1-6-r(2.β- dichlorQphenyUhio)ipethyn-<2-pγridipγn-g-propeno^te
2A (E Methyl 3-r3-r4-(4-methoxyphenyl)butyloxy1-6-r(2.6- dichlorophenvlthio)methvl1-2-pvridinvn-2-Oropenoate. 2,6-
Dichlorothiophenol (53mg, 0.297mmol, Aldrich) was dissolved in dry MeCN (O.βOmL) and treated with 2-(E-2-carboxymethylethenyl)-3-[4-(4- methoxyphenyl)butyloxy]-6-chloromethylpyridine hydrochloride (llδmg, 0.270mmol) and l,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.142mL, 0.949mmol). The reaction was stirred under an atmosphere of argon at 50 °C for 3h. The reaction solution was diluted with EtOAc and washed with H2O and brine and dried (MgSO-i). Purification by flash column chjomatography (silica, EtOAc: CH2CI2: hexane, 10: 15: 75) gave a colorless waxy solid: 1H NMR (250MHz, CDCI3) δ 7.94 (d, J=15.7Hz, 1H, vinyl), 7.31 (d, J==7.6Hz, 2H, aryl), 7.13 (m, 4H, aryl, pyridyl), 7.11 ^α, J=8.4Hz, 1H, pyridyl), 6.86 (d, J=8.7Hz, 2H, phenyl), 6.69 (d, J=15.7Hz, 1H, vinyl), 4.14 (s, 2H, CH2-S), 3.97 (t, J=6.1Hz, 2H, CH2-0), 3.80 (s, 3H, OMe), 3.78 (s, 3H, methyl ester), 2.63 (t, J=7.2Hz, 2H, benzylic), 1.81 (m, 4H, CH2CH2); analysis calcd. for C27H27C12N04S: C, 60.90; H, 5.11; N, 2.63; found: C, 60.61; H, 5.01; N, 2.57; MS (ES+): 532.0 (M+H).
Proceeding in a similar manner, but substituting for the intermediates listed in IA and IB the appropriate chloromethylpyridine and thiophenol or mercaptoalkylphenyl adducts, the following compounds can be prepared:
(E)-methyl 3-[3-[8-(4-methoxyphenyl)octyloxy]-6-[(3- carbomethoxybenzylthio)-methyl]-2-pyridinyl]-2-propenoate,
(E)-methyl 3-[3-[4-(4-methoxyphenyl)butyloxy]-6-[phenylthiomethyl]- 2-pyridinyl]-2-propenoate, and (E)-methyl 3-[3-[4-(4-methoxyρhenyl)butyloxy]-6-[(2,6-dichloro- phenylthio)methyl]-2-pyridinyl]-2-propenoate.
2B (E)-Lithiμm 3-f3-r4 4-metho?gyphenyl)bμtγloyyl-β-r(2,6- dichlorophenvlthio)methvn-2-pvridinvn-2-propenoate. (E)-Methyl 3-[3-[4- (4-methoxyphenyl)butyloxy]-6-[(2,6-dichlorophenylthio)methyl]-2- pyridinyl]-2-propenoate (65mg, 0.122mmol) was dissolved in THF (l.OmL) and MeOH (0.50mL) and treated with 1.0M LiOH (0.25mL, 0.25mmol). The reaction was stirred under an argon atmosphere for 20h. The solvent was evaporated and the product purified by Reversed Phased MPLC (RPr18 silica, H2θ-MeOH gradient). Lyophihzation yielded a colorless amorphous solid: 1H NMR (250MHz, d -MeOH) δ 7.68 (d, J=15.7Hz, 1H, vinyl), 7.37 (d, J=7.6Hz, 2H, aryl), 7.13 (m, 4H, aryl, pyridyl), 7.02 (d, J=8.4Hz, 1H, pyridyl), 6.82 (d, J=15.7Hz, 1H, vinyl), 6.81 (d, J=8.7Hz, 2H, phenyl), 4.13 (s, 2H, CH2-S), 4.00 (t, J=6.1Hz, 2H, CH2-0), 3.75 (s, 3H, OMe), 2.62 (t, J=7.2Hz, 2H, benzylic), 1.80 (m, 4H, CH2CH2); analysis calcd. for
C26H24Cl2N04SLi - 15/8H20: C, 55.95; H, 5.01; N, 2.51; found: C, 55.75; H, 4.58; N, 2.36; MS (ES+): 518.0 (M+H, free acid).

Claims

What, is claimed is:
1. A process for making a compound of formula I
Figure imgf000011_0001
where the Rj contains an α,β-unsaturated carbonyl group and the designation (R)n is hydrogen or one or more non-hydrogen radicals covalently bonded to the pyridyl and phenyl rings and m is 0 -5; which process comprises coupling a chloromethylpyridine of formula II with a thiol of formula III in the presence of 2 to 5 equivalents of 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) under an inert gas at a temperature between about ambient and 100° C for a period sufficient to effect the coupling.
Figure imgf000011_0002
Formula H Formula HI where Rj is defined above, m is 0 - 5 and (R)n is hydrogen or one or more radicals which can be substituted on either the pyridyl or phenyl ring and which does not have a functional group which interferes with the coupling reaction.
2. The process of claim 1 where about 3 equivalents of DBU is used and the reaction is carried out in acetonitrile under argon at a temperature of about 50° C for 2 to 4 hours.
3. The process of claim 2 wherein the product is a compound of formula IA
Figure imgf000011_0003
or an N-oxide, or a pharmaceutically acceptable salt, where R is Ci to C20- phatic, unsubstituted or substituted phenyl-Cj to Cio-aliphatic where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo, or R is Cj to C20-aliphatic-O-, or R is unsubstituted or substituted phenyl-Ci to Cio-aliphatic-0- where substituted phenyl has one or more radicals selected from the group consisting of lower alkoxy, lower alkyl, trihalomethyl, and halo;
Rl is -(CH2)xCH=CHCORy> or -(CH2)xCH=CHCHO, where x is 0 - 2 and Ry is -OH or an ester thereof or NH2 or a substituted amide derivative thereof;
R2 is H, lower alkoxy, halo, -CN, -(CH2)nR4 where n is 0 - 5, lower alkyl, or CF3;
R3 is H, lower alkoxy, halo, lower alkyl, CF3, -CN, -(CH2)nR4 where n is 0 - 5, R4 is tetrazol-5-yl or COR5; and
R5 is lower alkoxy, CH3(CH2)θ-6CO or phenyl(CH2)θ-3CO.
PCT/US1993/006177 1992-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates WO1994000433A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002138955A CA2138955A1 (en) 1992-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates
AU46557/93A AU678979B2 (en) 1992-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates
EP93916841A EP0649408A4 (en) 1992-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates.
US08/356,353 US5700943A (en) 1993-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates
JP50263894A JP3181917B2 (en) 1992-06-30 1993-06-30 Method for producing phenylthiomethylpyridinylalkenoates
KR1019940704738A KR950702184A (en) 1992-06-30 1994-12-24 Process for making phenylthi omethypyridinylalkenoates

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90695192A 1992-06-30 1992-06-30
US07/906,951 1992-06-30
US2520093A 1993-03-02 1993-03-02
US08/025,200 1993-03-02

Publications (1)

Publication Number Publication Date
WO1994000433A1 true WO1994000433A1 (en) 1994-01-06

Family

ID=26699426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/006177 WO1994000433A1 (en) 1992-06-30 1993-06-30 Process for making phenylthiomethylpyridinylalkenoates

Country Status (10)

Country Link
EP (1) EP0649408A4 (en)
JP (1) JP3181917B2 (en)
KR (1) KR950702184A (en)
CN (1) CN1095713A (en)
AU (1) AU678979B2 (en)
CA (1) CA2138955A1 (en)
MX (1) MX9303972A (en)
NZ (1) NZ254473A (en)
TW (1) TW247907B (en)
WO (1) WO1994000433A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733044A1 (en) * 1993-12-08 1996-09-25 Smithkline Beecham Corporation Compounds
WO1996033174A1 (en) * 1995-04-21 1996-10-24 Smithkline Beecham Plc New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314666C (en) * 2005-12-19 2007-05-09 华中师范大学 Method for synthesizing thioether compound by aid of microwave
KR200481393Y1 (en) * 2014-08-06 2016-09-27 김상열 Smart slim stand

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3810379A1 (en) * 1988-03-26 1989-10-12 Hoechst Ag AZANEOPHYL AND SILAZANEOPHYL SULFIDES, METHOD FOR THE PRODUCTION THEREOF, CONTAINERS THEREOF AND THEIR USE AS A PEST CONTROL
JPH07116150B2 (en) * 1990-06-07 1995-12-13 スミスクライン・ビーチャム・コーポレイション Benzoic acid derivative
JPH06501019A (en) * 1990-09-13 1994-01-27 スミスクライン・ビーチャム・コーポレイション Pyridylthio or pyridyloxyalkanoic acid
JPH06510786A (en) * 1991-09-19 1994-12-01 スミスクライン・ビーチャム・コーポレイション Pyridine compounds for the treatment of leukotriene-related diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Org. Chem., Vol. 53, issued 1988, TROST et al., "Tetra-N-Butylammonium Oxone. Oxidations under Anhydrous Conditions", pages 532-537, esp. pg. 535, see entire document. *
See also references of EP0649408A4 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733044A1 (en) * 1993-12-08 1996-09-25 Smithkline Beecham Corporation Compounds
EP0733044A4 (en) * 1993-12-08 1997-03-05 Smithkline Beecham Corp Compounds
WO1996033174A1 (en) * 1995-04-21 1996-10-24 Smithkline Beecham Plc New form of (e)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid
US6093828A (en) * 1995-04-21 2000-07-25 Smithkline Beecham P.L.C. Form of (E)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridi nyl]-2-propenoic acid

Also Published As

Publication number Publication date
CA2138955A1 (en) 1994-01-06
AU4655793A (en) 1994-01-24
JPH07508283A (en) 1995-09-14
TW247907B (en) 1995-05-21
EP0649408A1 (en) 1995-04-26
EP0649408A4 (en) 1995-06-21
AU678979B2 (en) 1997-06-19
JP3181917B2 (en) 2001-07-03
MX9303972A (en) 1994-04-29
NZ254473A (en) 1996-11-26
KR950702184A (en) 1995-06-19
CN1095713A (en) 1994-11-30

Similar Documents

Publication Publication Date Title
EP2235001B1 (en) Process for preparing pyridinone compounds
US8329905B2 (en) Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
US20070249837A1 (en) Process for the Preparation of Pyridine Derivatives
KR0139639B1 (en) Process for the preparation of substituted 2-chloropyridines
CS183391A3 (en) Process for preparing dialkylpyridine-2,3-dicarboxylates and derivatives thereof
KR20220158761A (en) Preparation of cyclosporine derivatives
JPH06510786A (en) Pyridine compounds for the treatment of leukotriene-related diseases
WO1994000433A1 (en) Process for making phenylthiomethylpyridinylalkenoates
KR0130975B1 (en) Method for the preparation of herbicidal o-carboxyarylimidazolinone compounds
US5700943A (en) Process for making phenylthiomethylpyridinylalkenoates
JP2771994B2 (en) Method for producing propenoic acid derivative
EP0388620B1 (en) Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones
US6252082B1 (en) Pyridone derivatives, their preparation and their use as synthesis intermediates
JPH04243875A (en) Process for producing 2-phenyl-6-(pyrimidin-2- yl)pyridine compound, intermediate compound and process for producing intermediate compound
JPS62120393A (en) Manufacture of fluorine-containing derivatives of phosphonicacid and compounds thereby
KR20020015031A (en) Synthesis of 3-amino-3-aryl propanoates
JP3907721B2 (en) Method for producing 2-aralkyloxypyridines
KR860001392B1 (en) Process for the preparation of 2-(2-methyl-3-chloroaniline)-3lysine nicotinate
JPH0558985A (en) Production of cyanoguanidine derivative
KR0134906B1 (en) Intermediate compound of herbicidal
JPH0253764A (en) Production of dithiobisphenol
JP3272170B2 (en) Method for producing pyridine derivative
JPH1059964A (en) Production of arylamide of heterocyclic aromatic carboxylic acid
JPH0625169A (en) Production of 2-amino-5-methylpyridine
JPS5817751B2 (en) Method for producing isoxazole derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 08356353

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2138955

Country of ref document: CA

Ref document number: 254473

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1993916841

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993916841

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993916841

Country of ref document: EP